EDF Health

Compounding the problem: Why aren’t we using the safest and most effective dispersants in the Gulf?

Richard Denison, Ph.D., is a Senior Scientist.

Imagine learning you have a serious disease.  Your doctor decides to treat you with a drug, noting it could have some bad side effects.  He also plans to inject you with the drug, even though it’s only been used orally before now.  That makes you nervous enough to ask for the name of the drug. “Sorry, I can’t tell you,” he says.  “It’s proprietary.”  Even if you trust your doctor, you’re now left with no way to investigate the risks and tradeoffs you’re facing.

Imagine how mad you’d be if you learned your doctor hadn’t told you there were other drugs that not only had fewer side effects, but were more effective in treating your condition.  And then you learn he’s on the Board of Directors of the company that makes the drug he prescribed.

Now consider that the patient is the Gulf of Mexico, the doctor is BP, and the drug is the oil dispersants, sold by Nalco under the trade name Corexit®, more than 500,000 gallons of which have been applied to date, with no end in sight.  Read More »

Also posted in Environment, Health policy, Regulation / Tagged , , , , , | Read 8 Responses

Raising the bar for chemical safety will spur, not stifle, innovation

Richard Denison, Ph.D., is a Senior Scientist.

An emerging chemical industry talking point in TSCA reform is the claim that imposing new requirements on new chemicals will somehow stifle innovation.  The milder manifestation of this perspective emanates from those who oppose requiring a safety determination for new chemicals unless they raise major red flags in an initial review.

But some in the industry go further, arguing that even requiring safety data for new chemicals would put the big chill on development of new chemicals.

I beg to differ with both arguments.  This post will make the opposite case, and will also argue that true innovation embraces rather than shuns safety, and demands the information needed to demonstrate it. Read More »

Also posted in Health policy, Regulation / Tagged , , , , , , , , , , , , | Read 5 Responses

Yes, Virginia (and all 49 other states), chemicals do cause cancer

Richard Denison, Ph.D., is a Senior Scientist.

Please help me welcome to the true mainstream of scientific and medical thought the seemingly radical yet commonsense notion that chemical exposures are a significant contributor to cancer, many types of which are rising in incidence even as overall rates decline.

This morning, the President’s Cancer Panel released its 2010 report [available here].  The report is remarkable not so much for its core finding that chemical exposures are a major factor in human cancer, but rather because of its source — an authoritative and bipartisan body — and because of the strong linkages it makes to our failed chemicals policies.

Read More »

Also posted in Health policy / Tagged , , , | Authors: / Read 1 Response

A minimum data set: Why, what, how much and when?

Richard Denison, Ph.D., is a Senior Scientist.

As I noted in my last post, EDF and the Safer Chemicals Healthy Families coalition believe TSCA needs to ensure that basic safety data are developed and made available for all chemicals in commerce.  Such information is:

  • a core element of the public’s right-to-know;
  • embodied in the “no data, no market” concept already in place under the EU’s REACH; and
  • most importantly, critical for identifying BOTH:
    •  chemicals of concern we have not yet identified, due to data gaps; and
    • chemicals  presenting little or no concern, which may serve as safer alternatives to chemicals of concern but we need to be able to identify with greater confidence.

The chemical industry’s opposition to comprehensive data requirements is an inherent contradiction:  It is often the first to claim “regrettable substitution” when a chemical is restricted, asking: “How do we know the substitute is any better?”  The answer is we often won’t – UNLESS we take a comprehensive approach to data development

So what types of data, and how much, should comprise a minimum safety data set?  And when should it be submitted? Read More »

Also posted in Health policy, Regulation / Tagged , , , , | Read 1 Response

A minimum data set: Who needs it?

Richard Denison, Ph.D., is a Senior Scientist.

Sound chemicals management and control demands sound information.  The Safer Chemicals Healthy Families coalition believes information sufficient to determine a chemical’s safety needs to be provided for all chemicals, as a condition for them to enter (for new chemicals) or remain (for existing chemicals) on the market.

Needed chemical information is not limited to test data, and even for types of data that can be derived from testing, alternative sources and approaches may be appropriately used.  Given the large number of chemicals for which information is needed, the availability of various sources of information, and the desirability of minimizing cost and use of laboratory animals, all reasonable efforts should be made to use existing information and data derived from the use of validated alternative methods – as long as the information they provide is current and scientifically reliable.

But who needs such information? Read More »

Also posted in Health policy, Regulation / Tagged , , , , , | Comments are closed

Not just kids’ play any more: TSCA reform gets serious

Richard Denison, Ph.D., is a Senior Scientist.

Today, at long last, legislation to reform the Toxic Substances Control Act (TSCA) hit the streets.  A bill, the Safe Chemicals Act of 2010, was introduced by Senator Lautenberg in the U.S. Senate.  And just to keep things interesting and all of us on our toes, Congressmen Rush and Waxman today released the Toxic Chemicals Safety Act of 2010 that is similar but not identical and is in the form of a discussion draft, rather than a bill.

It’s been a long road to get here, but of course this is only the end of the beginning.

EDF and the Safer Chemicals Healthy Families coalition support the new legislative language and believe it includes most of the elements needed to move our outdated and broken chemical safety system into the 21st century.  We also will be seeking improvements in several areas as the bill moves forward.

For our coalition’s initial perspective on the positive aspects as well as some of the shortcomings of the legislative proposals, see the news release we issued today.  We will also soon be posting an analysis that aligns the bill’s and discussion draft’s provisions with the planks of our platform, and I’ll provide an update with a link here. Read More »

Also posted in Health policy / Tagged , , , , , | Read 3 Responses